For Investors

Investor Relations

Latest Press Releases

All Press Releases
Date Title
October 21, 2020
Novan to Present at the Virtual Investor KOL Roundtable
October 14, 2020
Novan’s NITRICIL™ Technology Shows In Vitro Antiviral Effect Against SARS-CoV-2 in Human Airway Infection Model
September 24, 2020
Novan Strengthens Financial Leadership with Appointments of Chief Financial Officer and Seasoned Industry Executive to Board of Directors
September 14, 2020
Novan Provides Pipeline and Priority Development Programs Update

Recent SEC Filings

All SEC Filings

Upcoming Events

More 
More events are coming soon.

Stock Information

more

Exchange
Volume
Today's Open
Previous Close

Data as of Oct 22, 2020 12:09 AM EDT

Data Provided by Refinitiv. Minimum 15 minutes delayed.

October 21, 2016
October 21, 2016

Corporate Governance

Click here to view our Corporate Governance information.

IR & Media Contact

Information Request

Click here to request information.

Presentation

More
October 14, 2020

Annual Report

More
July 23, 2020

Analyst Coverage

more
Firm Analyst
HC Wainwright & Co.
Oren Livnat, CFA
Zacks Small-Cap Research
John D. Vandermosten, CFA
JMP Securities
Donald Ellis, Pharm.D.

Novan, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Novan, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Novan, Inc. or its management. Novan, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Transfer Agent

E-mail Alerts

  • Sign up here to get latest notifications whenever Novan inc. posts new information to the site.